Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fergus J Couch

Showing results (341-350 of 544) with videos related to

Pageof 55
Sort By:
Journal of the National Cancer Institute|March 24, 2010
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survivalElizabeth M Azzato, Jonathan Tyrer, Peter A Fasching, et al.
Human Molecular Genetics|April 26, 2012
Identification of a novel percent mammographic density locus at 12q24Kristen N Stevens, Sara Lindstrom, Christopher G Scott, et al.
Oncotarget|August 29, 2015
SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survivalMaral Jamshidi, Rainer Fagerholm, Sofia Khan, et al.
Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.
Scientific Reports|April 28, 2018
E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association ConsortiumHisani N Horne, Hannah Oh, Mark E Sherman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variantsHongyan Li, Christoph Engel, Miguel de la Hoya, et al.
Breast Cancer Research and Treatment|December 17, 2008
No evidence that GATA3 rs570613 SNP modifies breast cancer riskSharon E Johnatty, Fergus J Couch, Zachary Fredericksen, et al.
Cancer Research|April 12, 2015
Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density MeasuresJennifer Stone, Deborah J Thompson, Isabel Dos Santos Silva, et al.
Nature Cancer|December 30, 2022
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasisSusana Garcia-Recio, Toshinori Hinoue, Gregory L Wheeler, et al.
JCO Precision Oncology|September 14, 2019
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSarah M Nielsen, Diana M Eccles, Iris L Romero, et al.
Pageof 55

Showing results (341-350 of 544) with videos related to

Sort By:
Pageof 55
Journal of the National Cancer Institute|March 24, 2010
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survivalElizabeth M Azzato, Jonathan Tyrer, Peter A Fasching, et al.
Human Molecular Genetics|April 26, 2012
Identification of a novel percent mammographic density locus at 12q24Kristen N Stevens, Sara Lindstrom, Christopher G Scott, et al.
Oncotarget|August 29, 2015
SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survivalMaral Jamshidi, Rainer Fagerholm, Sofia Khan, et al.
Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.
Scientific Reports|April 28, 2018
E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association ConsortiumHisani N Horne, Hannah Oh, Mark E Sherman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variantsHongyan Li, Christoph Engel, Miguel de la Hoya, et al.
Breast Cancer Research and Treatment|December 17, 2008
No evidence that GATA3 rs570613 SNP modifies breast cancer riskSharon E Johnatty, Fergus J Couch, Zachary Fredericksen, et al.
Cancer Research|April 12, 2015
Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density MeasuresJennifer Stone, Deborah J Thompson, Isabel Dos Santos Silva, et al.
Nature Cancer|December 30, 2022
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasisSusana Garcia-Recio, Toshinori Hinoue, Gregory L Wheeler, et al.
JCO Precision Oncology|September 14, 2019
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSarah M Nielsen, Diana M Eccles, Iris L Romero, et al.
Pageof 55